Challenges for the Pharmaceutical Research Industry Interview with Birgit Fischer, Managing Director of the Association of Research-Based Pharmaceutical Companies (vfa)

被引：0

作者：

Riemann, J. F. ^{[1
]}

Fischer, Birgit ^{[1
]}

机构：

[1] Verbandes Forschender Arzneimittelhersteller Vfa, Berlin, Germany

来源：

GASTROENTEROLOGE | 2018年 / 13卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S23 / S25

页数：3

共 50 条

[1] Challenges for the research-based Pharmaceutical Industry Interview with Birgit Fischer, Chief Executive Officer of the Association of Research-Based Pharmaceutical Companies (vfa)
Riemann, J. F.
Fischer, Birgit
[J]. GASTROENTEROLOGE, 2016, 11 (05): : 435 - 437
[2] Evaluation of paediatric study applications. Experiences of the members of the German Association of Research-Based Pharmaceutical Companies (vfa)
Dullweber, F.
Riedel, A.
Boehler, S.
[J]. MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (07) : 662 - +
[3] Corporate responsibility in the research-based pharmaceutical industry
Suchanek, Andreas
Lin-Hi, Nick
[J]. JAHRBUCHER FUR NATIONALOKONOMIE UND STATISTIK, 2007, 227 (5-6): : 547 - 562
[4] Contribution of research-based pharmaceutical companies in Germany to personalised medicine
Turulski, E.
Matusiewicz, D.
[J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 451 - 451
[5] Doctors see Therapeutic Freedom at Risk This was the Result of a Survey commissioned by the Association of Research-Based Pharmaceutical Companies (VFA) and the NAV-Virchow-Bund
不详
[J]. GASTROENTEROLOGE, 2009, 4 (01): : 84 - 84
[6] Impact of the Clinical Trials Directive on the Research-Based Pharmaceutical Industry
Moira Daniels
[J]. International Journal of Pharmaceutical Medicine, 2004, 18 (1) : 5 - 8
[7] Changing R&D models in research-based pharmaceutical companies
Alexander Schuhmacher
Oliver Gassmann
Markus Hinder
[J]. Journal of Translational Medicine, 14
[8] Orphan Drugs from the Perspective of research-based Pharmaceutical and Biotech Companies
Sydow, Sabine
Throm, Siegfried
[J]. INTERNIST, 2019, 60 (04): : 405 - 410
[9] Changing R&D models in research-based pharmaceutical companies
Schuhmacher, Alexander
Gassmann, Oliver
Hinder, Markus
[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
[10] Pharmacovigilance Committee Activities of the Association of Research-Based Pharmaceutical Companies after the Release of Pharmacovigilance Regulation in Turkey
Erkahraman, A.
Nefesoglu, Z.
Epcell, S.
[J]. DRUG SAFETY, 2011, 34 (10) : 944 - 944

← 1 2 3 4 5 →